UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-09 | -0.92 | -0.92 |
| Q1 2022 | 2022-05-10 | -0.78 | -0.78 |
| Q4 2021 | 2022-03-01 | -1.05 | -1.05 |
| Q3 2021 | 2021-11-09 | -0.95 | -0.95 |
| Q2 2021 | 2021-08-09 | -0.85 | -0.85 |
| Q1 2021 | 2021-05-10 | -0.65 | -0.65 |
| Q4 2020 | 2021-02-25 | -0.76 | -0.76 |
| Q3 2020 | 2020-11-03 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-10 | -0.96 | -0.96 |
| 2016-06-30 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-06-29 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-06-22 | Reiterated Rating | Piper Jaffray | Overweight | $57.00 |
| 2016-06-22 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-06-22 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $57.00 |
| 2016-06-01 | Initiated Coverage | Piper Jaffray | Overweight | $57.00 |
| 2016-04-30 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-04-28 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-04-16 | Reiterated Rating | Leerink Swann | Outperform | |
| 2016-03-29 | Reiterated Rating | SunTrust | Top Pick | $60.00 |
| 2016-03-29 | Reiterated Rating | SunTrust Banks Inc. | Top Pick | $60.00 |
| 2016-03-21 | Reiterated Rating | Leerink Swann | Outperform | $95.00 |
| 2016-03-09 | Lower Price Target | JMP Securities | Market Outperform | $62.00 to $55.00 |
| 2015-12-11 | Reiterated Rating | Leerink Swann | Buy | |
| 2015-11-06 | Lower Price Target | JMP Securities | Market Outperform | $62.00 |
| 2015-11-06 | Boost Price Target | RBC Capital | Outperform | $62.00 to $74.00 |
| 2015-11-06 | Boost Price Target | Royal Bank Of Canada | Outperform | $62.00 to $74.00 |
| 2015-09-29 | Boost Price Target | Guggenheim | Buy | $95.00 to $104.00 |
| 2015-09-18 | Reiterated Rating | Cowen and Company | Buy | |
| 2015-09-18 | Boost Price Target | Leerink Swann | Outperform | $39.00 to $95.00 |
| 2015-09-17 | Boost Price Target | SunTrust | $50.00 to $60.00 | |
| 2015-09-17 | Reiterated Rating | Ladenburg Thalmann | Buy | $54.00 to $75.00 |
| 2015-09-17 | Boost Price Target | Guggenheim | Buy | $36.00 to $95.00 |
| 2015-09-17 | Boost Price Target | Cowen and Company | Outperform | $62.00 to $75.00 |
| 2015-09-16 | Reiterated Rating | RBC Capital | Outperform | $42.00 to $62.00 |
| 2015-09-16 | Reiterated Rating | SunTrust | Buy | |
| 2015-09-16 | Reiterated Rating | Leerink Swann | Buy | $39.00 |
| 2015-08-06 | Reiterated Rating | Cowen and Company | Outperform | $29.00 to $62.00 |
| 2015-08-03 | Reiterated Rating | Leerink Swann | Buy | |
| 2015-06-18 | Reiterated Rating | SunTrust | Buy | $50.00 |
| 2015-06-09 | Initiated Coverage | Guggenheim | Buy | $36.00 |
| 2015-05-07 | Reiterated Rating | Leerink Swann | Outperform | $35.00 to $39.00 |
| 2015-05-06 | Initiated Coverage | SunTrust | Buy | $50.00 |
| 2015-04-14 | Initiated Coverage | RBC Capital | Outperform | $41.00 |
| 2015-03-09 | Boost Price Target | Cowen and Company | $29.00 | |
| 2015-01-02 | Initiated Coverage | JMP Securities | Outperform | |
| 2014-12-23 | Initiated Coverage | JMP Securities | Outperform | $26.00 |
| 2014-08-13 | Reiterated Rating | Leerink Swann | Outperform | $34.00 to $35.00 |
| 2014-03-06 | Initiated Coverage | Guggenheim | Buy | $27.00 |
| 2014-02-26 | Initiated Coverage | Cowen and Company | Outperform | $28.00 |
| 2013-12-23 | Initiated Coverage | Leerink Swann | Outperform |
| 2016-06-30 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-06-29 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-06-22 | Reiterated Rating | Piper Jaffray | Overweight | $57.00 |
| 2016-06-22 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-06-22 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $57.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ITCI 189 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| FMR LLC | 10.27M |
| Vanguard Group, Inc | 8.12M |
| BlackRock Inc. | 7.10M |
| WASATCH ADVISORS INC | 5.24M |
| WELLINGTON MANAGEMENT CO LLP | 5.16M |
| ALLIANCEBERNSTEIN L.P. | 2.20M |
| BlackRock Fund Advisors | 2.03M |
| LORD, ABBETT & CO. LLC | 2.02M |
| STATE STREET CORP | 1.98M |
| FRANKLIN RESOURCES INC | 1.80M |
| Invesco Ltd. | 1.68M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.62M |
| GANNETT WELSH & KOTLER | 1.47M |
| BlackRock Institutional Trust Company, N.A. | 0.94M |
| NORTHERN TRUST CORP | 0.93M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| ALAFI MOSHE | 13.45% (3953270) | ITCI / |
| ALAFI CAPITAL CO LLC | 13.45% (3953270) | ITCI / |
| Sosland Morton I. | 7.48% (2198554) | ITCI / |
| Mates Sharon Chairman, President & CEO | 3.70% (1088707) | ITCI / |
| Alafi Christopher D | 2.54% (746155) | ITCI / STXS / |
| Fienberg Allen A. VP of Business Development | 0.67% (197823) | ITCI / |
| Wennogle Lawrence P. Vice President, Drug Discovery | 0.43% (126500) | ITCI / |
| RIGGS RORY B | 0.13% (37296) | FGEN / ITCI / |
| Davis Robert E SVP, Chief Scientific Officer | 0.10% (29397) | ITCI / |
| MARCUS JOEL S | 0.07% (21671) | ARE / ATRA / ITCI / PMT / REXR / |
| Hineline Lawrence J. VP of Finance CFO | 0.06% (17032) | ITCI / |
| Vanover Kimberly E. VP, Clinical Development | 0.04% (12373) | ITCI / |
| LERNER RICHARD A | 0.03% (10223) | ITCI / OPK / SQNM / |
| VAN NOSTRAND ROBERT L | 0.01% (3893) | ACHN / GALE / ITCI / MBLX / |
UM